Krensavage Asset Management buys $20,839,713 stake in Halyard Health Inc (HYH)

Halyard Health Inc (HYH) : Krensavage Asset Management scooped up 12,917 additional shares in Halyard Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 575,206 shares of Halyard Health Inc which is valued at $20,839,713.Halyard Health Inc makes up approximately 7.20% of Krensavage Asset Management’s portfolio.

Other Hedge Funds, Including , Cornerstone Capital Management Holdings. boosted its stake in HYH in the latest quarter, The investment management firm added 107,400 additional shares and now holds a total of 142,200 shares of Halyard Health Inc which is valued at $5,151,906. Halyard Health Inc makes up approx 0.04% of Cornerstone Capital Management Holdings.’s portfolio. Tower Research Capital (trc) added HYH to its portfolio by purchasing 3,199 company shares during the most recent quarter which is valued at $115,900. Halyard Health Inc makes up approx 0.01% of Tower Research Capital (trc)’s portfolio.Brown Advisory Inc reduced its stake in HYH by selling 70 shares or 0.88% in the most recent quarter. The Hedge Fund company now holds 7,898 shares of HYH which is valued at $284,328.Retirement Systems Of Alabama boosted its stake in HYH in the latest quarter, The investment management firm added 94 additional shares and now holds a total of 60,202 shares of Halyard Health Inc which is valued at $2,048,072. Halyard Health Inc makes up approx 0.01% of Retirement Systems Of Alabama’s portfolio.

Halyard Health Inc opened for trading at $36.47 and hit $36.91 on the upside on Monday, eventually ending the session at $36.84, with a gain of 1.18% or 0.43 points. The heightened volatility saw the trading volume jump to 1,69,156 shares. Company has a market cap of $1,719 M.

On the company’s financial health, Halyard Health Inc reported $0.45 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.36. The company had revenue of $400.00 million for the quarter, compared to analysts expectations of $382.39 million. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS.

Many Wall Street Analysts have commented on Halyard Health Inc. Company shares were Reiterated by Deutsche Bank on Aug 10, 2016 to “Buy”, Firm has raised the Price Target to $ 41 from a previous price target of $36 .Company shares were Reiterated by Stifel on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 38 from a previous price target of $37 .Company shares were Reiterated by Stifel on Jun 14, 2016 to “Buy”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Halyard Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Halyard Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.